Representative Kevin Hern Sells Shares of Novo Nordisk A/S
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Novo Nordisk A/S (NYSE: NVO). A filing disclosed on September 25th revealed that the Representative sold between $1,001 and $15,000 worth of Novo Nordisk A/S stock on September 10th. This transaction was made through the Representative's "KEVIN HERN TRADITIONAL IRA" account. Novo Nordisk A/S is a Denmark-based global pharmaceutical company specializing in treatments for diabetes, obesity, and other chronic diseases. Its product portfolio includes injectable and oral medicines for diabetes, such as insulin products and GLP-1 therapies like Ozempic and Rybelsus, as well as the obesity treatment Wegovy. The company also develops and markets products for rare blood disorders, growth hormone therapies, and hormone replacement treatments. Shares of NVO opened at $38.69 on Tuesday, with a market capitalization of $172.77 billion.
